A comprehensive four-year follow-up on acromegaly patients who had undergone surgery revealed that long-term treatment with lanreotide Autogel consistently controlled growth hormone (GH) and insulin-like growth factor I (IGF-I) levels. The gene discussed is IGF1; the disease is acromegaly.